A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema
NCT00479336
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
104
Enrollment
INDUSTRY
Sponsor class
Conditions
Cirrhosis
Interventions
DRUG:
OPC-41061 7.5mg
DRUG:
OPC-41061 placebo
DRUG:
OPC-41061 15mg
DRUG:
OPC-41601 30mg
Sponsor
Otsuka Pharmaceutical Co., Ltd.